Desonate
Loading...Desonate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Desonate Gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Patients should be instructed to use Desonate Gel for the minimum amount of time as necessary to achieve the desired results because of the potential for Desonate Gel to suppress the hypothalamic-pituitary-adrenal (HPA) axis (seePRECAUTIONS). Treatment should not exceed 4 consecutive weeks.
History
There is currently no drug history available for this drug.
Other Information
Desonate Gel contains desonide (pregna-1,4-diene-3, 20-dione,11, 21-dihydroxy-16, 17-[(1-methylethylidene) bis(oxy)]-, (11ß,16α)- a synthetic nonfluorinated corticosteroid for topical dermatologic use. Chemically, desonide is C24H32O6. It has the following structural formula:
Desonide has the molecular weight of 416.52. It is a white to off-white odorless powder which is soluble in methanol and practically insoluble in water.
Each gram of Desonate Gel contains 0.5 mg of desonide in an aqueous gel base of purified water, glycerin, propylene glycol, edetate disodium dihydrate, methylparaben, propylparaben, sodium hydroxide, and Carbopol® 981.
Sources
Desonate Manufacturers
-
Skinmedica
![Desonate (Desonide) Gel [Skinmedica]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Desonate | Skinmedica
Desonate Gel should be applied as a thin layer to the affected areas two times daily and rubbed in gently. Therapy should be discontinued when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended.
Desonate Gel should not be used with occlusive dressings.
-
Intendis Inc.
Desonate | Intendis Inc.
Apply a thin layer to the affected areas two times daily and rub in gently. Discontinue use when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended. Do not use with occlusive dressings. Avoid contact with eyes or other mucous membranes.
For topical use only. Not for oral, ophthalmic, or intravaginal use.
-
Bayer Healthcare Pharmaceuticals Inc.
Desonate | Bayer Healthcare Pharmaceuticals Inc.
Apply a thin layer to the affected areas two times daily and rub in gently. Discontinue use when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended. Do not use with occlusive dressings. Avoid contact with eyes or other mucous membranes.
For topical use only. Not for oral, ophthalmic, or intravaginal use.
![Desonate (Desonide) Gel [Intendis Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4ae18cfa-0451-466d-80cd-73f6748405b6&name=71fcf85b-04ff-4630-872d-cd2df7ba6842-02.jpg)
![Desonate (Desonide) Gel [Bayer Healthcare Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d7c46ed-e6c3-465b-be3d-16ecab43a9e7&name=42e806cf-4eaf-46df-90b6-edb6323eb09c-02.jpg)
Login To Your Free Account